Robotic-Assisted Minimally Invasive Mitral Valve Surgery
Historical Context and Development
- The American Heart Association acknowledges the first robotic-assisted minimally invasive mitral valve repairs using the da Vinci platform were performed independently in 1998 by Mohr et al. and Carpentier et al., followed closely by Chitwood et al. 1, 2, 3
- The results of the DaVinci trial, reported in 2005 by Nifong et al., established the safety and efficacy of the robotic platform for cardiac procedures, with a high level of evidence 1, 2, 3
- Multiple investigators have reported good to excellent outcomes in large series of patients undergoing robotic-assisted MIMVR, according to the American College of Cardiology 1, 2, 3
Technical Aspects of the da Vinci System
- The da Vinci surgical system has evolved through several models, including the standard da Vinci robot, the da Vinci S, and the newer da Vinci Si model, which offers dual console capabilities for training, as noted by the Society of Thoracic Surgeons 4, 5
Training and Credentialing for Robotic Surgery
- A structured robotic surgery training curriculum (RSTC) includes both preclinical and clinical components to minimize the impact of surgical education on patient outcomes, with a moderate level of evidence, according to the American Urological Association 4, 5, 6
- Preclinical training involves didactic sessions, hands-on tutorials, dry lab practice, virtual reality simulation, and animate or cadaveric robotic training for complex procedural tasks, as recommended by the European Association of Urology 4, 6, 7
- Clinical training requires a graduated, step-wise progression under expert supervision, with the trainee advancing through increasingly difficult steps as proficiency is demonstrated, according to the American Urological Association 5, 8
Patient Selection for Robotic-Assisted MIMVR
- The ideal candidate for robotic-assisted MIMVR is a patient with suitable anatomy, providing generous intrathoracic workspace, as noted by the Society of Thoracic Surgeons 3
- Patient anatomy and vascular status are critical considerations for suitability for the robotic approach, with a high level of evidence, according to the American College of Cardiology 3
Challenges and Limitations
- The high cost of the system, especially with advanced features like the dual console, can be prohibitive for many training programs, as noted by the American Urological Association 5
- The da Vinci Si model with dual console capability allows for expert surgeon direction and supervision during training, enhancing the educational experience, with a moderate level of evidence, according to the European Association of Urology 5
Robotic Mitral Valve Repair Guidelines
Primary Indications
- The American Heart Association and American College of Cardiology recommend robotic mitral valve repair for patients with chronic severe primary mitral regurgitation with symptoms, regardless of left ventricular function, when performed by highly experienced surgeons at high-volume centers 9, 10, 11
- Robotic MVR is indicated for asymptomatic severe primary mitral regurgitation with left ventricular dysfunction (LVEF <60% or LVESD ≥40 mm) 9, 12
- The American College of Cardiology recommends robotic MVR for asymptomatic severe primary mitral regurgitation with preserved left ventricular function when repair likelihood exceeds 95% with <1% mortality at a Heart Valve Center of Excellence 13
- Robotic MVR is indicated for asymptomatic severe primary mitral regurgitation with new-onset atrial fibrillation or pulmonary hypertension (PA systolic pressure >50 mm Hg) 13
Ideal Patient Selection
- The ideal robotic MVR candidate has isolated mitral valve disease without significant aortic pathology 14, 15
- Posterior leaflet prolapse is a favorable condition for robotic MVR, with a >90% success rate expected 9, 11, 16
Clinical Benefits
- Robotic MVR demonstrates equivalent or superior perioperative outcomes compared to sternotomy, with reduced pleural effusion rates and lower wound infection rates 14
- The American College of Cardiology states that robotic MVR provides measurable quality of life improvements, including shorter hospital stay and faster return to preoperative functional activity 14
Repair Quality and Durability
- The quality of mitral valve repair is equivalent across all approaches when performed by experienced surgeons, with operative mortality <1% for posterior leaflet prolapse 9, 11, 16
- Robotic MVR achieves 95% freedom from reoperation at 15-20 years and >80% freedom from recurrent moderate-severe mitral regurgitation at 15-20 years 9, 11, 16
Critical Caveats
- The success of robotic MVR is heavily dependent on surgeon and center volume, with centers performing >140 mitral operations annually achieving 77% repair rates vs 48% at low-volume centers (<36 cases/year) 9, 10
- Hospital mortality is 50% lower at highest-volume centers 9, 10
- Previous cardiac surgery is not a contraindication to robotic approach and may actually avoid complexities of repeat sternotomy 17